Relationships to similar clinical features, which we observed in AAA, can indicate, that activation and increased expression of NADPH oxidases in aneurysmatic vessel wall can be greatly affected by “simple” clinical risk factors of AAA development. Here, FMO5 is linked to triple-A syndrome.